by | Feb 5, 2025 | Lupus Foundation of America
Black History Month is a time to honor the strength, resilience, and contributions of the Black community. This year, we’re focusing on the theme “Your Voice, Your Power” to highlight the importance of self-advocacy in healthcare settings.Self-advocacy means using...
by | Feb 4, 2025 | Lupus Foundation of America, News & Events
In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE). Researchers surveyed 767 participants from the GOAL cohort, the...
by | Feb 3, 2025 | Lupus Foundation of America, News & Events
The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene Therapeutics’ ALLO-329, an investigational allogenicCAR-T cell therapy. Researchers are preparing to a initiate the Phase 1 RESOLUTION trial in mid-2025...
by | Feb 3, 2025 | Lupus Foundation of America, News & Events
The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene Therapeutics’ ALLO-329, an investigational allogenicCAR-T cell therapy. Researchers are preparing to a initiate the Phase 1 RESOLUTION trial in mid-2025...
by | Feb 3, 2025 | Lupus Foundation of America, News & Events
The Centers for Medicare and Medicaid Services (CMS) issued final payment determinations for Progentec Diagnostics’ proprietary tests, the aiSLE DX Flare Risk Index (FRI) and aiSLE DX Disease Activity Index (DAI) biomarker tests. Starting on January 1, 2025, Medicare...
by | Feb 1, 2025 | Lupus Foundation of America
Nyobie’s journey with lupus is a story of resilience, empowerment, and the transformative strength of finding her voice. Diagnosed in 2010 after a difficult 19-year journey through eight different doctors, Nyobie has lived through the complexities of a chronic illness...
